COLUMBIA, Md.--(BUSINESS WIRE)--CELSION CORPORATION (AMEX: CLN) today announced that a ThermoDox Phase I liver cancer clinical abstract has been accepted for oral presentation at the 2008 Society of Interventional Radiology (SIR) conference. The SIR is hosting this Annual Scientific Meeting in Washington, DC from March 15th to 20th, 2008. This annual meeting provides advances in research, new devices, world-renowned presenters and training fundamentals for medical professionals in the non-surgical field of interventional radiology.
